Publications by authors named "Zifan Yu"

Claim this Profile
T
The simplification of the symptom Checklist-90 scale utilizing machine learning techniques.
Zifan Yu, Jiehui Yang, Jianfeng Tan, Xiaowan Zou, Jiajie Su

J Affect Disord· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Machine learning-enabled high-throughput industry screening of edible oils.
Peishan Deng, Xiaomin Lin, Zifan Yu, Yuanding Huang, Shijin Yuan

Food Chem· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BulkLMM: Real-time genome scans for multiple quantitative traits using linear mixed models.
Zifan Yu, Gregory Farage, Robert W Williams, Karl W Broman, Śaunak Sen

bioRxiv· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of orthodontic pain on dental anxiety: a review.
Lili Xie, Yanan Ma, Xue Sun, Zifan Yu

J Clin Pediatr Dent· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of Voretigene Neparvovec for Biallelic RPE65-Mediated Inherited Retinal Disease: Phase 3 Results at 3 and 4 Years.
Albert M Maguire, Stephen Russell, Daniel C Chung, Zi-Fan Yu, Amy Tillman

Ophthalmology· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis.
Sabrina Paganoni, Suzanne Hendrix, Samuel P Dickson, Newman Knowlton, Eric A Macklin, Hong Yu, Zi-Fan Yu

Muscle Nerve· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy, Safety, and Durability of Voretigene Neparvovec-rzyl in RPE65 Mutation-Associated Inherited Retinal Dystrophy: Results of Phase 1 and 3 Trials.
Albert M Maguire, Stephen Russell, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu

Ophthalmology· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toward the Identification of Extra-Oral TAS2R Agonists as Drug Agents for Muscle Relaxation Therapies via Bioinformatics-Aided Screening of Bitter Compounds in Traditional Chinese Medicine.
Mingzhi Luo, Kai Ni, Yang Jin, Zifan Yu, Linhong Deng

Front Physiol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mobility test to assess functional vision in patients with inherited retinal dystrophies.
Daniel C Chung, Sarah McCague, Zi-Fan Yu, Satha Thill, Julie DiStefano-Pappas

Clin Exp Ophthalmol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, retrospective medical record review of X-linked myotubular myopathy: The recensus study.
Alan H Beggs, Barry J Byrne, Sabine De Chastonay, Tmirah Haselkorn, Imelda Hughes, Zi-Fan Yu, Sabrina W Yum

Muscle Nerve· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequent source plasma donors are not at risk of iron depletion: the Ferritin Levels in Plasma Donor (FLIPD) study.
George B Schreiber, Roger Brinser, Marilyn Rosa-Bray, Zi-Fan Yu, Toby Simon

Transfusion· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65-mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial.
Stephen Russell, Jean Bennett, Jennifer A Wellman, Daniel C Chung, Zi-Fan Yu

Lancet· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive endpoints for therapy development for neuronopathic mucopolysaccharidoses: Results of a consensus procedure.
Johanna H van der Lee, Jonathan Morton, Heather R Adams, Lorne Clarke, Berendine Johanne Ebbink, Zi-Fan Yu

Mol Genet Metab· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of kidney function on outcomes following high risk myocardial infarction: findings from 27 610 patients.
George V Moukarbel, Zi-Fan Yu, Kenneth Dickstein, Yingxin Rachel Hou, Janet T Wittes

Eur J Heart Fail· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.
Paul Harmatz, Zi-Fan Yu, Roberto Giugliani, Ida Vanessa D Schwartz, Nathalie Guffon

J Inherit Metab Dis· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy for mucopolysaccharidosis VI: Growth and pubertal development in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase.
Celeste Decker, Zi-Fan Yu, Roberto Giugliani, Ida Vanessa D Schwartz, Nathalie Guffon

J Pediatr Rehabil Med· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simulation study of quantitative risk assessment for bivariate continuous outcomes.
Zi-Fan Yu, Paul J Catalano

Risk Anal· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of endurance and safety outcomes during enzyme replacement therapy for mucopolysaccharidosis VI: Final results of three clinical studies of recombinant human N-acetylgalactosamine 4-sulfatase.
Paul Harmatz, Roberto Giugliani, Ida Vanessa D Schwartz, Nathalie Guffon, Elisa Leão Teles, Zi-Fan Yu

Mol Genet Metab· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endovascular stent grafting versus open surgical repair of descending thoracic aortic aneurysms in low-risk patients: a multicenter comparative trial.
Joseph E Bavaria, Jehangir J Appoo, Michel S Makaroun, Joel Verter, Zi-Fan Yu

J Thorac Cardiovasc Surg· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enzyme replacement therapy for mucopolysaccharidosis VI: a phase 3, randomized, double-blind, placebo-controlled, multinational study of recombinant human N-acetylgalactosamine 4-sulfatase (recombinant human arylsulfatase B or rhASB) and follow-on, open-label extension study.
Paul Harmatz, Roberto Giugliani, Ida Schwartz, Nathalie Guffon, Elisa Leão Teles, Zi-Fan Yu

J Pediatr· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative risk assessment for multivariate continuous outcomes with application to neurotoxicology: the bivariate case.
Zi-Fan Yu, Paul J Catalano

Biometrics· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase.
Paul Harmatz, David Ketteridge, Roberto Giugliani, Natalie Guffon, Elisa Leão Teles, Zi-Fan Yu

Pediatrics· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis